Author:
Perno Carlo-Federico,Moyle Graeme,Tsoukas Chris,Ratanasuwan Winai,Gatell Jose,Schechter Mauro
Subject
Infectious Diseases,Virology
Reference86 articles.
1. TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1
2. Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment
3. , , , , , . 2006. Use of TMC114 in combination with other drugs. Guidance from Pharmacokinetic Studies Eighth International Congress on Drug Therapy in HIV Infection, 12–16 November, Glasgow, UK, Abstract PL5.1.
4. How Does Expert Advice Impact Genotypic Resistance Testing in Clinical Practice?
5. Less Than 95% Adherence to Nonnucleoside Reverse‐Transcriptase Inhibitor Therapy Can Lead to Viral Suppression
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献